Clinical Trial Update: A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate single and multiple doses of HRS-6257 in healthy subjects for pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• HRS-6257 (HRS-6257)

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Pain | Phase 1 | Status: RECRUITING